The Oncology Institute, Inc. (STLN) — Cash Flow Quality Index

Latest as of December 2022: -37.27x

The Oncology Institute, Inc. (STLN) has a Cash Flow Quality Index of -37.27x as of December 2022. Operating cash flow of $-61.76 Million is below net income of $1.66 Million, suggesting accrual-heavy earnings not yet converted to cash. See how much free cash does The Oncology Institute, Inc. generate to measure how efficiently the company converts operating cash flow to free cash.

Cash Flow Quality Index

-37.27x
Operating CF / Net Income

Operating Cash Flow

$-61.76 Million
USD

Net Income

$1.66 Million
USD

Data as of

Dec 2022
Most recent filing

The Oncology Institute, Inc. Cash Flow Quality Index (2022–2022)

Historical Cash Flow Quality Index for The Oncology Institute, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore STLN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Quality Index for The Oncology Institute, Inc. (2022–2022)

Year-by-year earnings quality comparison for The Oncology Institute, Inc.. For the full cash flow conversion analysis, see The Oncology Institute, Inc. (STLN) cash conversion ratio.

Year Quality Index Operating CF (USD) Net Income YoY Change
2022 -37.27x $-61.76 Million $1.66 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.